Latest Articles
Sur180 gets nearly $2.4M NIH grant to develop non-hormonal endo treatment - News is My Business
Sur180 gets nearly $2.4M NIH grant to develop non-hormonal endo treatment News is My Business
Published: July 9, 2025, 9:03 a.m.
Kirsten Storms Was ‘Taken Aback’ When She Learned She’d Be Temporarily Replaced on ‘General Hospital’ - Yahoo
Kirsten Storms Was ‘Taken Aback’ When She Learned She’d Be Temporarily Replaced on ‘General Hospital’ Yahoo
Published: July 8, 2025, 3:55 a.m.
The Problem of Endometriosis in the UK - Pharmafile
The Problem of Endometriosis in the UK Pharmafile
Published: July 7, 2025, 10:55 a.m.
Women with PCOS, endometriosis and hyperthyroidism embrace matcha as TikTok highlights hormone health benefits - lbc.co.uk
Women with PCOS, endometriosis and hyperthyroidism embrace matcha as TikTok highlights hormone health benefits lbc.co.uk
Published: July 4, 2025, 12:56 p.m.
Endometriosis market to grow to $2.5 bn across 7MM in 2034 - Express Pharma
Endometriosis market to grow to $2.5 bn across 7MM in 2034 Express Pharma
Published: July 4, 2025, 8:30 a.m.
Who Replaced Kirsten Storms as Maxie on General Hospital? Recast Status Explained - ComingSoon.net
Who Replaced Kirsten Storms as Maxie on General Hospital? Recast Status Explained ComingSoon.net
Published: July 4, 2025, 7:33 a.m.
General Hospital coming and goings: How long will Kirsten Storms be gone? - Soap Central
General Hospital coming and goings: How long will Kirsten Storms be gone? Soap Central
Published: July 3, 2025, 10:40 p.m.
Lurgan beauty queen hopes to ‘make history’ for NI in Florida competition - Armagh I
Lurgan beauty queen hopes to ‘make history’ for NI in Florida competition Armagh I
Published: July 3, 2025, 3:56 p.m.
Endometriosis Treatment Market Transforming Patient Care with Targeted Solutions - Precedence Research
Endometriosis Treatment Market Transforming Patient Care with Targeted Solutions Precedence Research
Published: July 3, 2025, 1:37 p.m.
Organon drops OG-6219 development following trial miss - The Pharma Letter
Organon drops OG-6219 development following trial miss The Pharma Letter
Published: July 3, 2025, 10:55 a.m.
Link copied to clipboard!